Aerovate Therapeutics, Inc. (AVTE) Entity Common Stock, Shares Outstanding 2021 - 2024

Historical data

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aerovate Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from 2021 to 2024.
  • Aerovate Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 21, 2024 was 27.9 M shares, a 12.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 27.9 M +3.05 M +12.3% Mar 21, 2024 10-K 2024-03-25
Q3 2023 27.7 M +3.06 M +12.5% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 27.6 M +3.2 M +13.1% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 24.8 M +402 K +1.65% Mar 27, 2023 10-K 2023-03-29
Q3 2022 24.6 M +195 K +0.8% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 24.4 M +37.8 K +0.16% Aug 11, 2022 10-Q 2022-08-15
Q1 2022 24.4 M Mar 29, 2022 10-K 2022-03-30
Q3 2021 24.4 M Nov 12, 2021 10-Q 2021-11-15
Q2 2021 24.4 M Aug 13, 2021 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.